Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by K. Aggarwal
Early Release Science of the exoplanet WASP-39b with JWST NIRSpec PRISM - Nature
Authors and Affiliations Department of Earth and Planetary Sciences, Johns Hopkins University, Baltimore, Maryland, USA Z. Rustamkulov & D. K. Sing Department of Physics & Astronomy, Johns Hopkins University, Baltimore, MD, USA D. K. Sing, N. H. Allen & L. Ramos-Rosado Department of Astronomy & Astrophysics, University of California, Santa Cruz, Santa Cruz, CA, 95064, USA S. Mukherjee, A. L. Carter, N. M. Batalha, J. J. Fortney & K. Ohno Johns Hopkins APL, Laurel, MD, USA E. M. May, K. B. Stevenson & J.
Publisher Correction: A repeating fast radio burst associated with a persistent radio source - Nature
Author notes These authors contributed equally: C.-H. Niu, K. Aggarwal, D. Li Authors and Affiliations National Astronomical Observatories, Chinese Academy of Sciences, Beijing, China C.-H. Niu, D. Li, C.-W. Tsai, Y.-K. Zhang, P. Wang, Y. Feng, G.-D. Li, C.-C. Miao, J.-R. Niu, W.-Y. Wang, M. Yuan, Y.-L. Yue, D.-J. Zhou & W.-W. Zhu Department of Physics and Astronomy, West Virginia University, Morgantown, WV, USA K. Aggarwal, S. Burke-Spolaor, R. Anna-Thomas & J.
A repeating fast radio burst associated with a persistent radio source - Nature
Abstract The dispersive sweep of fast radio bursts (FRBs) has been used to probe the ionized baryon content of the intergalactic medium1, which is assumed to dominate the total extragalactic dispersion. Although the host-galaxy contributions to the dispersion measure appear to be small for most FRBs2, in at least one case there is evidence for an extreme magneto-ionic local environment3,4 and a compact persistent radio source5.
Abstract No. 584 PK simulation of Avatrombopag-induced increases in platelet counts with redosing in patients with thrombocytopenia and chronic liver disease
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Avatrombopag (AVA) is a novel oral thrombopoietin receptor agonist recently approved to treat thrombocytopenia in patients with chronic liver disease (CLD) scheduled to undergo a procedure; it is administered orally as a 5-day treatment course.
Journal of Vascular and Interventional Radiology
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with K.
Contact K., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack